VC fund profile · evidence-aware directory data
Frist Cressey Ventures stages, portfolio and investment profile
Nashville healthcare venture firm co-founded in 2016 by former U.S. Senate Majority Leader Bill Frist, MD and Bryan Cressey. Backs early-stage companies transforming care delivery with technology and tech-enabled services, including AI-native models. Closed oversubscribed Fund IV at $425M (Feb 2026 PR), bringing firm AUM toward ~$1B. Strategic LP network includes The Cigna Group, MedStar Health, and OhioHealth. HQ at 40 Burton Hills Blvd, Nashville, TN.
Keep track of Frist Cressey Ventures
Save this profile to your VCT watchlist for a quick return.
Stage-based planning range
$1M–$10M
This is a planning range inferred from stage coverage, not a firm-disclosed check size.
Methodology: Stage bucket inferred from the rounds a fund leads or invests in.
No firm-specific check-size disclosure is recorded.
Investment stages
Leads: Seed, Series A, Series B
Participates: Seed, Series A, Series B, Growth
Sector focus
healthtech · biotech-life-sciences · ai-ml · enterprise-saas
Geography
Nashville, TN
Founded 2016
Fund size / AUM
Fund IV $425M; ~$1B firm AUM (Feb 2026 PR)
A separate fund-size evidence record is not yet available.
Portfolio in our directory
3
Linked startup profiles
Recent tracked investment
Not recorded
No dated round explicitly links this fund.
Rounds they lead
Rounds they invest
Last verified: Not recorded. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.
Related reading
Recent investments, portfolio developments and our research on this investor.
Portfolio companies we track
Startups in our directory that list Frist Cressey Ventures as an investor (3 total).
- Abby Care Clinically supported family-caregiving provider combining caregiver training, pay and care documentation.
- Monogram Health Value-based in-home kidney and polychronic care delivery plus benefit management for health plans.
- Thyme Care Value-based oncology care navigation and support platform for cancer patients.
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.